• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于预测结肠癌预后的新型十七基因代谢标志物。

A Novel Seventeen-Gene Metabolic Signature for Predicting Prognosis in Colon Cancer.

机构信息

Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.

出版信息

Biomed Res Int. 2020 Nov 17;2020:4845360. doi: 10.1155/2020/4845360. eCollection 2020.

DOI:10.1155/2020/4845360
PMID:33282950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7685801/
Abstract

A metabolic disorder is considered one of the hallmarks of cancer. Multiple differentially expressed metabolic genes have been identified in colon cancer (CC), and their biological functions and prognostic values have been well explored. The purpose of the present study was to establish a metabolic signature to optimize the prognostic prediction in CC. The related data were downloaded from The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx) database, and Gene Expression Omnibus (GEO) combined with GSE39582 set, GSE17538 set, GSE33113 set, and GSE37892 set. The differentially expressed metabolic genes were selected for univariate Cox regression and lasso Cox regression analysis using TCGA and GTEx datasets. Finally, a seventeen-gene metabolic signature was developed to divide patients into a high-risk group and a low-risk group. Patients in the high-risk group presented poorer prognosis compared to the low-risk group in both TCGA and GEO datasets. Moreover, gene set enrichment analyses demonstrated multiple significantly enriched metabolism-related pathways. To sum up, our study described a novel seventeen-gene metabolic signature for prognostic prediction of colon cancer.

摘要

代谢紊乱被认为是癌症的标志之一。在结肠癌(CC)中已经鉴定出多种差异表达的代谢基因,并且它们的生物学功能和预后价值已经得到了很好的探索。本研究的目的是建立一个代谢特征,以优化 CC 的预后预测。相关数据从癌症基因组图谱(TCGA)、基因-组织表达(GTEx)数据库和基因表达综合数据库(GEO)中下载,与 GSE39582 集、GSE17538 集、GSE33113 集和 GSE37892 集相结合。使用 TCGA 和 GTEx 数据集,对差异表达的代谢基因进行单变量 Cox 回归和套索 Cox 回归分析。最后,开发了一个由十七个基因组成的代谢特征,将患者分为高风险组和低风险组。在 TCGA 和 GEO 数据集中,高风险组的患者预后均比低风险组差。此外,基因集富集分析表明,多个与代谢相关的途径显著富集。总之,我们的研究描述了一个新的十七个基因代谢特征,用于预测结肠癌的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbe/7685801/ff3baec62670/BMRI2020-4845360.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbe/7685801/d1328814ae78/BMRI2020-4845360.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbe/7685801/141635595e96/BMRI2020-4845360.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbe/7685801/6eda22fc4ed6/BMRI2020-4845360.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbe/7685801/d340ec2b9d89/BMRI2020-4845360.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbe/7685801/2914f2c56c9d/BMRI2020-4845360.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbe/7685801/f105e40cb919/BMRI2020-4845360.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbe/7685801/40417d7da8ed/BMRI2020-4845360.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbe/7685801/ff3baec62670/BMRI2020-4845360.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbe/7685801/d1328814ae78/BMRI2020-4845360.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbe/7685801/141635595e96/BMRI2020-4845360.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbe/7685801/6eda22fc4ed6/BMRI2020-4845360.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbe/7685801/d340ec2b9d89/BMRI2020-4845360.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbe/7685801/2914f2c56c9d/BMRI2020-4845360.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbe/7685801/f105e40cb919/BMRI2020-4845360.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbe/7685801/40417d7da8ed/BMRI2020-4845360.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbe/7685801/ff3baec62670/BMRI2020-4845360.008.jpg

相似文献

1
A Novel Seventeen-Gene Metabolic Signature for Predicting Prognosis in Colon Cancer.一种用于预测结肠癌预后的新型十七基因代谢标志物。
Biomed Res Int. 2020 Nov 17;2020:4845360. doi: 10.1155/2020/4845360. eCollection 2020.
2
Development and validation of a novel epigenetic signature for predicting prognosis in colon cancer.开发和验证新型表观遗传标志物预测结肠癌预后
J Cell Physiol. 2020 Nov;235(11):8714-8723. doi: 10.1002/jcp.29715. Epub 2020 Apr 24.
3
Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.构建免疫相关列线图预测Ⅰ期宫颈癌复发生存风险。
Biomed Res Int. 2021 Jul 9;2021:6699131. doi: 10.1155/2021/6699131. eCollection 2021.
4
Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.基于RNA测序的8长非编码RNA特征预测食管癌生存情况的鉴定
Med Sci Monit. 2016 Dec 28;22:5163-5172. doi: 10.12659/msm.902615.
5
A 65‑gene signature for prognostic prediction in colon adenocarcinoma.用于预测结肠腺癌预后的 65 基因标志物。
Int J Mol Med. 2018 Apr;41(4):2021-2027. doi: 10.3892/ijmm.2018.3401. Epub 2018 Jan 18.
6
Glucose metabolism-based signature predicts prognosis and immunotherapy strategies for colon adenocarcinoma.基于葡萄糖代谢的特征可预测结肠腺癌的预后和免疫治疗策略。
J Gene Med. 2024 Jan;26(1):e3620. doi: 10.1002/jgm.3620. Epub 2023 Nov 16.
7
Construction and validation of a metabolic risk model predicting prognosis of colon cancer.构建并验证一个用于预测结肠癌预后的代谢风险模型。
Sci Rep. 2021 Mar 25;11(1):6837. doi: 10.1038/s41598-021-86286-z.
8
Development and validation of a metabolic gene signature for predicting overall survival in patients with colon cancer.开发和验证用于预测结肠癌患者总生存期的代谢基因标志物。
Clin Exp Med. 2020 Nov;20(4):535-544. doi: 10.1007/s10238-020-00652-1. Epub 2020 Aug 8.
9
Novel gene signatures for prognosis prediction in ovarian cancer.新型基因标志物用于预测卵巢癌的预后。
J Cell Mol Med. 2020 Sep;24(17):9972-9984. doi: 10.1111/jcmm.15601. Epub 2020 Jul 14.
10
A nine-gene signature to improve prognosis prediction of colon carcinoma.一种九基因标志物,可改善结肠癌的预后预测。
Cell Cycle. 2021 May;20(10):1021-1032. doi: 10.1080/15384101.2021.1919827. Epub 2021 May 14.

引用本文的文献

1
Identification of a metabolic-immune signature associated with prognosis in colon cancer and exploration of potential predictive efficacy of immunotherapy response.鉴定与结肠癌预后相关的代谢-免疫特征并探索免疫治疗反应的潜在预测效力。
Clin Exp Med. 2025 Jan 24;25(1):46. doi: 10.1007/s10238-025-01566-6.
2
Mechanistic insights into zearalenone-accelerated colorectal cancer in mice using integrative multi-omics approaches.使用整合多组学方法对玉米赤霉烯酮加速小鼠结直肠癌的机制洞察
Comput Struct Biotechnol J. 2023 Feb 28;21:1785-1796. doi: 10.1016/j.csbj.2023.02.048. eCollection 2023.
3
Hsa_circ_0046430 promotes the progression of colorectal cancer by targeting miR-6785-5p/SRCIN1 axis as a ceRNA.

本文引用的文献

1
GPX2 silencing relieves epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer by downregulating Wnt pathway.GPX2 沉默通过下调 Wnt 通路缓解胰腺癌中的上皮-间充质转化、侵袭和转移。
J Cell Physiol. 2020 Nov;235(11):7780-7790. doi: 10.1002/jcp.29391. Epub 2019 Nov 27.
2
Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.胍氨酸酶通过激活 NO-MAPKs-PI3K/Akt 通路促进肺腺癌细胞肿瘤发生。
Cell Death Dis. 2019 Nov 7;10(11):854. doi: 10.1038/s41419-019-2082-3.
3
Methionine Adenosyltransferase 1a (MAT1A) Enhances Cell Survival During Chemotherapy Treatment and is Associated with Drug Resistance in Bladder Cancer PDX Mice.
Hsa_circ_0046430 通过作为 ceRNA 靶向 miR-6785-5p/SRCIN1 轴促进结直肠癌的进展。
Medicine (Baltimore). 2023 Feb 22;102(8):e33064. doi: 10.1097/MD.0000000000033064.
4
Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics.靶向癌症特异性代谢途径以开发新型癌症治疗方法。
Front Immunol. 2022 Dec 22;13:955476. doi: 10.3389/fimmu.2022.955476. eCollection 2022.
5
Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy.各种样本的代谢组学研究推动糖尿病视网膜病变的生物标志物发现和发病机制阐明。
Front Endocrinol (Lausanne). 2022 Oct 27;13:1037164. doi: 10.3389/fendo.2022.1037164. eCollection 2022.
6
Construction and validation of four-metabolism related-long non-coding RNAs as potential signature in prognosis of colon cancer.构建和验证四种与代谢相关的长链非编码RNA作为结肠癌预后的潜在标志物
Transl Cancer Res. 2022 Apr;11(4):725-735. doi: 10.21037/tcr-21-2184.
7
Derivation and Clinical Validation of a Redox-Driven Prognostic Signature for Colorectal Cancer.一种基于氧化还原驱动的结直肠癌预后标志物的推导与临床验证
Front Oncol. 2021 Oct 27;11:743703. doi: 10.3389/fonc.2021.743703. eCollection 2021.
8
Metabolomics: A Scoping Review of Its Role as a Tool for Disease Biomarker Discovery in Selected Non-Communicable Diseases.代谢组学:关于其作为选定非传染性疾病生物标志物发现工具作用的范围综述
Metabolites. 2021 Jun 25;11(7):418. doi: 10.3390/metabo11070418.
甲硫氨酸腺苷转移酶 1a(MAT1A)增强膀胱癌 PDX 小鼠化疗治疗期间的细胞存活并与耐药性相关。
Int J Mol Sci. 2019 Oct 9;20(20):4983. doi: 10.3390/ijms20204983.
4
A circRNA signature predicts postoperative recurrence in stage II/III colon cancer.环状 RNA 特征可预测 II/III 期结肠癌术后复发。
EMBO Mol Med. 2019 Oct;11(10):e10168. doi: 10.15252/emmm.201810168. Epub 2019 Sep 2.
5
Methylation Inactivates Expression of CDP-diacylglycerol Synthase 1 () in Hepatocellular Carcinoma.甲基化使肝细胞癌中CDP-二酰甘油合酶1()的表达失活。
Cancer Genomics Proteomics. 2006 May-Aug;3(3-4):231-238. Epub 2006 Jan 1.
6
An immune infiltration signature to predict the overall survival of patients with colon cancer.一种免疫浸润特征可预测结肠癌患者的总生存期。
IUBMB Life. 2019 Nov;71(11):1760-1770. doi: 10.1002/iub.2124. Epub 2019 Jul 13.
7
Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer.自噬相关标志物预测Ⅰ-Ⅲ期结肠癌早期复发的预后和预测价值。
Carcinogenesis. 2019 Jul 20;40(7):861-870. doi: 10.1093/carcin/bgz031.
8
Acyl-CoA dehydrogenase long chain expression is associated with esophageal squamous cell carcinoma progression and poor prognosis.酰基辅酶A脱氢酶长链表达与食管鳞状细胞癌进展及预后不良相关。
Onco Targets Ther. 2018 Oct 31;11:7643-7653. doi: 10.2147/OTT.S171963. eCollection 2018.
9
Comprehensive analysis of metastasis-related genes reveals a gene signature predicting the survival of colon cancer patients.对转移相关基因的综合分析揭示了一种预测结肠癌患者生存的基因特征。
PeerJ. 2018 Aug 21;6:e5433. doi: 10.7717/peerj.5433. eCollection 2018.
10
Metabolic reprogramming in colon cancer reversed by DHTS through regulating PTEN/AKT/HIF1α mediated signal pathway.通过调节 PTEN/AKT/HIF1α 介导的信号通路,DHTS 逆转结肠癌中的代谢重编程。
Biochim Biophys Acta Gen Subj. 2018 Oct;1862(10):2281-2292. doi: 10.1016/j.bbagen.2018.07.017. Epub 2018 Jul 20.